Silver Book Fact

~8.7 to 11.6 million people in the U.S. have heart valve disease

Fact image

Alliance for Aging Research generated statistics, based on year 2000 percentage prevalence estimates by Nkomo et al. 2006 AND Bach et al. 2007 AND U.S. Census 2016

Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E. Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?. Journal of Heart Valve Disease. 2007; 16(4). https://www.medscape.com/medline/abstract/17702360

Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano. Burden of Valvular Heart Diseases: a population-based study. Lancet. September 2006; 368(9540). http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?
Publication
Journal of Heart Valve Disease
Publication Date
2007
Authors
Bach D, Radeva J, Birnbaum H, Fournier A, Tuttle E
Volume & Issue
Volume 16, Issue 4
URL
Read Full Resource
Title
Burden of Valvular Heart Diseases: a population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • From 2010 to 2030, the total direct medical costs of cardiovascular disease (in 2008 dollars) are projected to triple–from $273 billion to $818 billion.  
  • Following the current path, pulmonary condition cases will increase by 31.3% between 2003 and 2023.  
  • In 2008, an estimated 770,000 Americans will have a new coronary attack, and about 430,000 will have a recurrent attack.  
  • Annual cost of treating privately insured patients for AFib
    The annual cost of treating privately insured patients for atrial fibrillation (AF) is $12,350 per patient— approximately 5 times greater than treating patients without AF.  
  • In 2003, $4.4 billion ($6,577 per discharge) was paid to Medicare beneficiaries for heart failure.